Reflections: Paul Bernard Chretien, MD (1931-2017)

The field of head and neck oncology and tumor immunology has lost one of its giants. Paul B. Chretien, MD died peacefully at home in Rockville, Maryland on August 16th, 2017 at age 86 after a prolonged decline in health. He was a true pioneer of head and neck tumor immunology and in the early 1970 ’s, adapted the emerging discoveries of the differing immune functions of T and B lymphocytes to the study of head and neck cancer patients. Working at the National Cancer Institute Surgery Branch as a Senior Investigator (1966-1972), and Chief of the Tumor Immunology Section (1972-1980), he was t he first to characterize deficiencies in T lymphocyte numbers and function in patients with head and neck cancer.
Source: Oral Oncology - Category: Cancer & Oncology Authors: Source Type: research